Gene Therapy in Sports Medicine

Authors: Lamsam C.1; Fu F.H.1; Robbins P.D.2; Evans C.H.1, 2

Source: Sports Medicine, Volume 25, Number 2, February 1998 , pp. 73-77(5)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $62.95 plus tax (Refund Policy)

Abstract:

Sports injuries frequently involve tissues that have limited healing capabilities. In order to improve the healing process and thus prevent the serious consequences of injury, it is necessary to understand the molecular and cellular biology of healing. Several growth factors and other cytokines have been identified as important mediators of a successful healing process. Such molecules have promise as novel agents for the treatment of sporting injuries, but there is presently no clinically useful way to deliver them. Gene transfer may be used to serve this purpose. In this role, gene therapy functions as a type of local biological drug delivery system. Recent studies have shown the feasibility of transferring marker genes to synovium, chondrocytes, meniscal fibrochondrocytes, tenocytes and ligamental fibroblasts, prompting optimism about the eventual success of this approach.

Keywords: Reviews-on-treatment; Sports-injuries; Gene-therapies, pharmacodynamics; Drug-delivery-systems

Language: English

Document Type: Opinion

Affiliations: 1: Department of Orthopedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA 2: Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA *

Publication date: 1998-02-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page